4.7 Review

The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases

Journal

NUTRIENTS
Volume 12, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/nu12082340

Keywords

choline; TMA; TMAO; non-alcoholic steatohepatitis (NASH); cardiovascular disease (CVD); chronic kidney diseases (CKD); probiotics; gut microbiota; polyphenols; fecal microbiota transplantation

Funding

  1. Ministry of Science, Innovation and Universities [PSI2017-83893-R]
  2. Ministry of Economy and Business (Spain) [PSI2015-73111-EXP, PSI2017-90806-REDT, AGL2017-83653R]
  3. postdoctoral Juan de la Cierva Contract (Ministry of Science, Innovation and Universities) [IJCI-2017-32156]

Ask authors/readers for more resources

Choline is a water-soluble nutrient essential for human life. Gut microbial metabolism of choline results in the production of trimethylamine (TMA), which, upon absorption by the host is converted into trimethylamine-N-oxide (TMAO) in the liver. A high accumulation of both components is related to cardiovascular disease, inflammatory bowel disease, non-alcoholic fatty liver disease, and chronic kidney disease. However, the relationship between the microbiota production of these components and its impact on these diseases still remains unknown. In this review, we will address which microbes contribute to TMA production in the human gut, the extent to which host factors (e.g., the genotype) and diet affect TMA production, and the colonization of these microbes and the reversal of dysbiosis as a therapy for these diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available